Catalyst Wire Dossier Catalyst Wire Dossier

Gene transfer therapy for recessive dystrophic epidermolysis bullosa

· Abeona Therapeutics, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene transfer therapy for recessive dystrophic epidermolysis bullosa, covering 2023-07-10 to 2023-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]

See pricing